TSE:CMED CanniMed Therapeutics (CMED) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CMED Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$27.00▼C$27.0052-Week Range N/AVolume52,208 shsAverage Volume387,394 shsMarket CapitalizationC$668.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get CanniMed Therapeutics alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About CanniMed Therapeutics Stock (TSE:CMED)CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada. As of March 28, 2018, CanniMed Therapeutics Inc. operates as a subsidiary of Aurora Cannabis Inc.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CMED Stock News HeadlinesJanuary 5, 2022 | investing.comCanniMed Therapeutics Inc (CMED)August 29, 2021 | foxnews.comMarine fired for criticizing military leaders resigns, says chasing stability makes ‘slave to the system’April 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.August 29, 2021 | msn.comSouth Sudan leaders agree deal to pave way for united army: ministerAugust 29, 2021 | msn.comI'm a Yale grad who charges students up to $85,000 a year for college prep - here's what it takes to get into the top schoolsAugust 29, 2021 | msn.comHome-based command center created to get Afghan allies outAugust 29, 2021 | news.yahoo.comHug led to investigation and Coast Guard Academy command master chief being relieved of dutiesAugust 29, 2021 | msn.comThe story of Jaswant Singh, the only Indian to have ever commanded a foreign Air ForceApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.August 29, 2021 | usatoday.comSoldier killed in Afghanistan was assigned to Fort Bragg special forces commandAugust 20, 2021 | nytimes.comKathy Hochul Is Shopping in New York City for a Second-in-CommandAugust 20, 2021 | news.yahoo.comExclusive-U.S. set to expand evacuation from Kabul to Europe- officialsAugust 19, 2021 | businessinsider.comHow China restructured its military to be a modern force that can flex its muscles overseasAugust 19, 2021 | nypost.comDesperate Afghan moms throw babies over barbed wire to UK troops at airportAugust 19, 2021 | chron.comCity, county react to indoor gathering recommendationAugust 18, 2021 | msn.comReview: How to command the Hollywood Bowl? Sheku Kanneh-Mason and Gustavo Dudamel show the wayAugust 18, 2021 | apnews.comFirst Command Reports: Financial Confidence Growing in Career Military FamiliesAugust 18, 2021 | apnews.comCommand Alkon Expands Leadership Team with Addition of New CRO to Fuel Next Stage of GrowthAugust 18, 2021 | news.yahoo.comBiden administration won’t commit to rescuing Americans trapped in Afghanistan after Aug. 31August 18, 2021 | msn.comKaweah Health Medical Center reactivates incident command center in response to patient surgeAugust 17, 2021 | msn.comNevada guardsmen respond to Afghanistan crisisAugust 17, 2021 | bizjournals.comCommand Alkon names Jeff Newlin chief revenue officerAugust 17, 2021 | msn.comPatch released for Fortinet command injection vulnerabilityAugust 17, 2021 | forbes.comChallenges And Solutions To Providing Healthcare To ImmigrantsAugust 17, 2021 | stockhouse.comHughes Awarded IDIQ Contract by U.S. Air Force to Offer Enterprise Satellite Networking SolutionsAugust 17, 2021 | msn.comCalls to One Hospital Command up to over 400 per day — VegaAugust 16, 2021 | msn.comA look inside the state fire marshal's mobile command centerSee More Headlines Receive CMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CanniMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryCannabis Current SymbolTSE:CMED CUSIPN/A CIKN/A Webwww.cannimedtherapeutics.com Phone+1-306-9751207FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares24,757,000Free FloatN/AMarket CapC$668.44 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Andre JeromeCEO & DirectorMr. John Lewis Knowles BComm. (Age 63)CPA, C.A., CFO, Corp. Sec. & Non-Independent Director Mr. Howard HarknessVP of Marketing & SalesKey CompetitorsCronos GroupCVE:MJNSirius XM CanadaTSE:XSRCanyon Services GroupTSE:FRCParamount Resources TECTSE:TETSandvineTSE:SVCView All Competitors CMED Stock Analysis - Frequently Asked Questions What other stocks do shareholders of CanniMed Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other CanniMed Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Smith & Nephew (SNN), Hydropothecary (THCX), CannTrust (CTST), Cronos Group (CRON), Cronos Group (MJN), CannaRoyalty (CNNRF), KushCo (KSHB) and Leaf Mobile (LEAF). How do I buy shares of CanniMed Therapeutics? Shares of CMED stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CMED) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CanniMed Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
